EUVIMEDEUVIMED entdecken
Crossref

Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer

Shuai Xu, Xinyi Zheng, Haibin Wu, Xujun You, Junwei Wu, Hai Zhou, Junhua Wu, Qianqian Liu, Ren-Qun Ye

Endokrynologia Polska · 2024

DOI: 10.5603/ep.99456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endokrynologia Polska, 2024. Verfasst von Shuai Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsThyroid NeoplasmsRNA, Long NoncodingHumansFemaleMaleGene Expression Regulation, NeoplasticFeasibility StudiesCell Line, TumorMiddle AgedBiomarkers, TumorApoptosisCell Proliferation

Stichwörter der Autor:innen

apoptosisdiagnosislncRNA DHRS4-AS1miR-222-3pproliferationthyroid cancer

Substanzen

MicroRNAsRNA, Long NoncodingBiomarkers, TumorMIR222, human

Autor:innen und Institutionen

  • Department of Endocrine, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Seventh College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Department of Andrology, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Preventive Treatment, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Dermatology, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Hepatic, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.

Zitieren

APA

Xu, S., Zheng, X., Wu, H., You, X., Wu, J., Zhou, H., Wu, J., Liu, Q., & Ye, R. Q. (2024). Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer. Endokrynologia Polska. https://doi.org/10.5603/ep.99456

Vancouver

Xu S, Zheng X, Wu H, You X, Wu J, Zhou H, et al. Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer. Endokrynologia Polska. 2024. doi:10.5603/ep.99456

BibTeX
@article{Xu2024,
  author = {Xu, Shuai and Zheng, Xinyi and Wu, Haibin and You, Xujun and Wu, Junwei and Zhou, Hai and Wu, Junhua and Liu, Qianqian and Ye, Ren-Qun},
  title = {Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer},
  journal = {Endokrynologia Polska},
  year = {2024},
  doi = {10.5603/ep.99456}
}
Kostenlos starten →